Stock Price
0.17
Daily Change
0 0%
Monthly
-27.66%
Yearly
-46.03%
Q2 Forecast
0.17

Paradigm Biopharmaceuticals reported AUD4.5K in Cost of Sales for its fiscal semester ending in December of 2025.





Cost Of Sales Change Date
Avita Medical AUD 3.3M 166K Dec/2025
Medical Developments International AUD 7.09M 4.91M Dec/2025
Neuren Pharmaceuticals AUD 7.45M 6.56M Jun/2025
Pacific Edge NZD 280K 0 Mar/2024
Telix Pharmaceuticals AUD 221.36M 20.78M Dec/2025